RxDoctor Payments Data

Christine Cheng, MD

Plastic Surgery · Bountiful, UTNPI 1306848338

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by TELA Bio, Inc. at 40.0% of the total. That places this record below the midpoint for plastic surgery clinicians in UT, where the typical reported total is $2,913.

$1,831in general payments, 2019–2025

Across 31 payments — averaging $59.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TELA Bio, Inc.$733
  • AbbVie$384
  • Integra Lifesciences Corporation$339
  • Solventum Corporation$200
  • Acera Surgical, Inc.$54
  • Mentor Worldwide LLC$52
  • plus $69 from 2 others
$250in research payments, 2019–2025

Across 1 payment — averaging $250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sientra, Inc.$250

What the payments were for

  • Food & beverage$1,831100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,831 in reported general payments places this provider in the 35th percentile of 71 plastic surgery providers in Utah.

See all plastic surgery providers in Utah

Medicare billing

Part B allowed, 2024
$8,716
Medicare patients
15
Services billed
35

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin19$215
Ondansetron Hcl12$42

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Bountiful

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →